Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A single center, randomized and double-blind phase II clinical trial is to be conducted in adults to evaluate the safety and immunogenicity of an inactivated pandemic influenza vaccine (whole-virion, aluminium-adjuvanted).
Epistemonikos ID: 0eed8c1131f9b68ec069d0d927986809a69ce07a
First added on: May 04, 2024